Authors : S. O. Abali; G. C. Onunkwo

Volume/Issue : Volume 9 - 2024, Issue 4 - April

Google Scholar : https://tinyurl.com/5n8fcfwn

Scribd : https://tinyurl.com/ycxa34vh

DOI : https://doi.org/10.38124/ijisrt/IJISRT24APR1028

Abstract : The preparation and assessment of solid lipid nanoparticles (SLNs) of nevirapine with improved oral delivery for better management of HIV/AIDS was the aim of this research. Eight batches of SLNs of nevirapine were produced from Dika wax and evaluated for particle charges and distribution of the sizes of particles using Zeta sizer, surface shape with Cryo-Transmission Electron Microspcope (Cryo-TEM), chemical interaction between drug and excipients with Fourier Transform Infrared Spectroscope (FTIR). Loading capacity, encapsulation efficiency and in vitro drug release properties were determined. Release profiles were compared with ƒ2 statistic, one-way ANOVA and students’t-test. From the results obtained, Cryo-TEM revealed that the SLNs were round to oval in shape with smooth external surface. Zeta sizer particle sizes and distribution analysis indicated quality results for Nevirapine SLN Batches 15 and 18. The zeta potential results were: -16.83 ± 0.404 mV for Batch 1, -44.30 ± 0.624 mV for Batch 15 and -40.03 ± 2.65 mV for Batch 18. Batches 15 and 18 SLNs had loading capacities of 6.71% and 9.82% respectively and encapsulation efficiencies of 49.35% and 70.19% respectively. In vitro dissolution showed 102% release for batch 18 and 87.5% release for Batch 15 with a dissolution efficiency of 65% for Batch 15 and 83% for Batch 18 SLNs. ƒ2 statistic, ANOVA and students’ t-test revealed Batch 15 SLNs are similar to Batch 18 SLN. In conclusion, Batches 15 and 18 SLNs have good properties for enhancing the delivery of nevirapine as extended release dosage forms for better management of HIV/AIDS.

Keywords : Solid Lipid Nanoparticle, Nevirapine, Dika Wax, HIV/AIDS.

References :

1. Swaminathan S, Ramachandran G, Agibothu Kupparam HK, Mahalingam V, Soundararajan L, Perumal Kannabiran B, et al. Factors influencing plasma nevirapine levels: a study in HIV-infected children on generic antiretroviral treatment in India. J Antimicrob Chemother. 2011 Jun; 66(6):1354–9.
2. Kou H, Du X, Li Y, Xie J, Qiu Z, Ye M, et al. Comparison of nevirapine plasma concentrations between lead-in and steady-state periods in Chinese HIV-infected patients. PLoS One. 2013; 8(1):e52950.
3. Frontiers | Follicular Dendritic Cells of Lymph Nodes as Human Immunodeficiency Virus/Simian Immunodeficiency Virus Reservoirs and Insights on Cervical Lymph Node | Immunology [Internet]. [cited 2022 Mar 16]. Available from: https://www.frontiersin.org/articles/10.3389/fimmu.2018.00805/full
4. Pottabathini V, Gugulothu V, Kaliyaperumal M, Battu S. Identification, Isolation and Characterization of Unknown Acid Degradation Product of Nevirapine. American Journal of Analytical Chemistry. 2016 Aug 26; 7(9):663–78.
5. Raju1 A, Reddy2 AJ, Satheesh1 J, Jithan1 AV. Preparation and characterisation of nevirapine oral nanosuspensions. Indian Journal of Pharmaceutical Sciences. 2014; 76(1):62.
6. Poovi G, Damodharan N. Lipid nanoparticles: A challenging approach for oral delivery of BCS Class-II drugs. Future Journal of Pharmaceutical Sciences. 2018 Dec 1; 4(2):191–205.
7. Ross SM. African Mango (IGOB131): A Proprietary Seed Extract of Irvingia gabonensis is Found to Be Effective in Reducing Body Weight and Improving Metabolic Parameters in Overweight Humans. Holistic Nursing Practice. 2011 Jul; 25(4):215–7.
8. Njoku OU, Ugwuanyi JO. Nutritional and Toxicological Properties of Dika Fat (Irvingia gabonensis). Journal of Herbs, Spices & Medicinal Plants. 1997 Jul 2; 4(4):53–8.
9. Irvingia. In: Wikipedia [Internet]. 2023 [cited 2023 Jul 26]. Available from: https://en.wikipedia.org/w/index.php?title=Irvingia&oldid=1134643705
10. E.E. Chinaeke et al. Formulation of Novel Artesunate-Loaded Solid Lipid Microparticles (SLMs) Based on Dika Wax Matrices: In Vitro and in Vivo Evaluation.  Journal of Drug Delivery Science and Technology. 2014; 24(1):69-77. Downloaded on 13th March, 2024 from:  https://www.sciencedirect.com/science/article/abs/pii/S177322471450010X.
11. Chime Salome Amarachi et al. Diclofenac potassium–loaded dika fat solid lipid microparticles: In vitro and in vivo characterisation. Journal of Pharmacy Research. 2013; 1(3):227-234. Downloaded on 12th March, 2024 from: https://www.researchgate.net/publication/271954615_Diclofenac_potassium-loaded_dika_fat_solid_lipid_microparticles_In_vitro_and_in_vivo_characterisation.
12. Sarkar M, Perumal OP, Panchagnula R. Solid-state characterization of nevirapine. Indian Journal of Pharmaceutical Sciences. 2008; 70(5):619.
13. Abali S. O., Ifeoma C. Ekenna, Ochen F. Scribd. Formulation and Characterization of Extended-Release Nevirapine Solid Dispersions. International Journal of Innovative Science and Research Technology. 2022; 7(3):588-594.
14. Harris J.R. (2015). Transmission electron microscopy in molecular structural biology: A historical survey. Arch Biochem Biophys, 581:3-18. doi:10.1016/j.abb.2014.11.011.
15. Clogston JD, Patri AK. Zeta potential measurement. Methods Mol Biol. 2011; 697:63–70.
16. Sarkar M, Perumal OP, Panchagnula R. Solid-state characterization of nevirapine. Indian Journal of Pharmaceutical Sciences. 2008; 70(5):619.
17. Jr S, Strattmann RR, Alburquerque MM, Araújo A, Matos J, Neto PJ. In vitro evaluation of dissolution profiles and thermal properties of some commercial formulations of nevirapine tablets. Acta Farmaceutica Bonaerense. 2006; 1(25):76–82.
18. Asrade B, Tessema E, Tarekegn A. In vitro comparative quality evaluation of different brands of carbamazepine tablets commercially available in Dessie town, Northeast Ethiopia. BMC Pharmacology and Toxicology. 2023 May 25; 24(1):35.
19. Shah VP, Tsong Y, Sathe P, Williams RL. Dissolution Profile Comparison Using Similarity Factor, f2. Dissolution Technol. 1999; 6(3):15–15.
20. Mishra P, Singh U, Pandey CM, Mishra P, Pandey G. Application of Student’s t-test, Analysis of Variance, and Covariance. Ann Card Anaesth. 2019; 22(4):407–11.
21. Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics. 2018 May 18; 10(2):57.
22. H S, M B, Tl D, Z H, As L, Ic S, et al. FTIR, Dissolution and Anti-viral Activity of Nevirapine Co-crystals. Pharm Anal Acta [Internet]. 2017 [cited 2021 Apr 26];08(09). Available from: https://www.omicsonline.org/open-access/ftir-dissolution-and-antiviral-activity-of-nevirapine-cocrystals-2153-2435-1000561.php?aid=94016
23. Zeta Potential - An Introduction | Malvern Panalytical [Internet]. [cited 2024 Jan 8]. Available from: https://www.malvernpanalytical.com/en/products/measurement-type/zeta-potential